GenSight Biologics
SIGHT.PA
#9710
Rank
C$46.74 M
Marketcap
$0.36
Share price
-0.65%
Change (1 day)
-40.40%
Change (1 year)

Earnings for GenSight Biologics (SIGHT.PA)

Earnings in 2023: -C$40.24 Million

According to GenSight Biologics's latest financial reports the company's current earnings are C$1.4 Million. In 2023 the company made an earning of -C$40.24 Million, an increase over its 2022 earnings that were of -C$41.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for GenSight Biologics from 2013 to 2023

Annual earnings

Year Earnings Change
2023-C$40.24 Million-2.16%
2022-C$41.12 Million-8.58%
2021-C$44.98 Million-22.54%
2020-C$58.07 Million21.01%
2019-C$47.99 Million-9.66%
2018-C$53.12 Million32.28%
2017-C$40.16 Million24.57%
2016-C$32.24 Million55.57%
2015-C$20.73 Million84%
2014-C$11.27 Million112.64%
2013-C$5.3 Million